Furthermore, there were evidences uncovering the associations between SLC5A2 and cardia cancer (OR = 13.666; 95% CI: 4.610-40.515; P-value < 0.0001), HCC (OR = 29.465; 95% CI: 6.568-132.195; P-value < 0.0001), and pancreatic cancer (OR = 8.096; 95%CI: 3.476–18.857; P-value < 0.0001). Here, SLC5A2 is linked to hepatocellular carcinoma.